This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Šegedin B, Merlo S, Smrkolj Š, Bebar S, Blatnik A, Cerar O, et al. [Recommendations in management of endometrial cancer]. [Slovenian]. Institute of Oncology Ljubljana: Radiotherapy and Oncology Society: Ljubljana; 2018.ŠegedinBMerloSSmrkoljŠBebarSBlatnikACerarOet al[Recommendations in management of endometrial cancer]. [Slovenian]Institute of Oncology Ljubljana: Radiotherapy and Oncology SocietyLjubljana2018Search in Google Scholar
Cancer in Slovenia 2017. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Slovenian Cancer Registry; 2020.Cancer in Slovenia2017LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer RegistrySlovenian Cancer Registry2020Search in Google Scholar
Corzo C, Barrientos Santillan N, Westin SN, Ramirez PT. Updates on conservative management of endometrial cancer. J Minim Invasive Gynecol 2018; 25: 308-13. doi: 10.1016/j.jmig.2017.07.022CorzoCBarrientosSantillan NWestinSNRamirezPT.Updates on conservative management of endometrial cancerJ Minim Invasive Gynecol2018253081310.1016/j.jmig.2017.07.02228782618Open DOISearch in Google Scholar
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 2016; 27: 16-41. doi: 10.1093/annonc/mdv484ColomboNCreutzbergCAmantFBosseTGonzález-MartínALedermannJet alESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-upAnn Oncol201627164110.1093/annonc/mdv48426634381Open DOISearch in Google Scholar
Neri M, Peiretti M, Melis GB, Piras B, Vallerino V, Paoletti AM, et al. Systemic therapy for the treatment of endometrial cancer. Expert Opin Pharmacother 2019; 20: 2019-32. doi: 10.1080/14656566.2019.1654996NeriMPeirettiMMelisGBPirasBVallerinoVPaolettiAMet alSystemic therapy for the treatment of endometrial cancerExpert Opin Pharmacother20192020193210.1080/14656566.2019.165499631451034Open DOISearch in Google Scholar
Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, Obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers 2014; 29: e21-9. doi: 10.5301/jbm.5000047ZhangYLiuHYangSZhangJQianLChenXOverweight, Obesity and endometrial cancer risk: results from a systematic review and meta-analysisInt J Biol Markers201429e21910.5301/jbm.500004724170556Open DOISearch in Google Scholar
Malik TY, Chishti U, Aziz AB, Sheikh I. Comparison of risk factors and survival of type 1 and type II endometrial cancers. Pak J Med Sci 2016; 32: 886-90. doi: 10.12669/pjms.324.9265MalikTYChishtiUAzizABSheikhIComparison of risk factors and survival of type 1 and type II endometrial cancersPak J Med Sci2016328869010.12669/pjms.324.9265501709627648033Open DOISearch in Google Scholar
Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ 2010; 340: c927. doi: 10.1136/bmj.c927HannafordPCIversenLMacfarlaneTVElliottAMAngusVLeeAJMortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception StudyBMJ2010340c92710.1136/bmj.c927283714520223876Open DOISearch in Google Scholar
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013; 31: 2607-18. doi: 10.1200/JCO.2012.48.2596SetiawanVWYangHPPikeMCMcCannSEYuHXiangY-Bet alType I and II endometrial cancers: have they different risk factors?J Clin Oncol20133126071810.1200/JCO.2012.48.2596369972623733771Open DOISearch in Google Scholar
Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. 4th edition. Lyon: International Agency for Research on Cancer, World Health Organization; 2014.KurmanRJCarcangiuMLHerringtonCSYoungRHeditorsWHO classification of tumours of female reproductive organs. 4th editionLyonInternational Agency for Research on Cancer, World Health Organization2014Search in Google Scholar
Arko D, Kozar N, Rmuš M, Takač I. The reliability of preoperative determination of tumour grade in endometrial cancer. Zdrav Vest 2018; 87: 167-75. doi: 10.6016/ZdravVestn.2495ArkoDKozarNRmušMTakačI.The reliability of preoperative determination of tumour grade in endometrial cancerZdrav Vest2018871677510.6016/ZdravVestn.2495Open DOISearch in Google Scholar
Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, et al. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin 2019; 69: 258-79. doi: 10.3322/caac.21561BrooksRAFlemingGFLastraRRLeeNKMoroneyJWSonCHet alCurrent recommendations and recent progress in endometrial cancerCA Cancer J Clin2019692587910.3322/caac.2156131074865Open DOISearch in Google Scholar
Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer 2016; 15: 423-7. doi: 10.1007/s10689-016-9893-5HampelHGenetic counseling and cascade genetic testing in Lynch syndromeFam Cancer201615423710.1007/s10689-016-9893-526969309Open DOISearch in Google Scholar
Hinchcliff EM, Bednar EM, Lu KH, Rauh-Hain JA. Disparities in gynecologic cancer genetics evaluation. Gynecol Oncol 2019; 153: 184-91. doi: 10.1016/j.ygyno.2019.01.024HinchcliffEMBednarEMLuKHRauh-HainJADisparities in gynecologic cancer genetics evaluationGynecol Oncol20191531849110.1016/j.ygyno.2019.01.024643069130711300Open DOISearch in Google Scholar
National Comprehensive Cancer Network. Genetic/familial high-risk assessment: colorectal: Version 1.2020 - July 21, 2020. [cited 2021 Jan 11]. Available at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdfNational Comprehensive Cancer Network. Genetic/familial high-risk assessment: colorectal: Version 1.2020 - July 212020[cited 2021 Jan 11]. Available athttps://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdfSearch in Google Scholar
Daniels MS, Lu KH. Genetic predisposition in gynecologic cancers. Semin Oncol 2016; 43: 543-7. doi: 10.1053/j.seminoncol.2016.08.005DanielsMSLuKHGenetic predisposition in gynecologic cancersSemin Oncol201643543710.1053/j.seminoncol.2016.08.00527899185Open DOISearch in Google Scholar
Farooq A, Walker LJ, Bowling J, Audisio RA. Cowden syndrome. Cancer Treat Rev 2010; 36: 577-83. doi: 10.1016/j.ctrv.2010.04.002FarooqAWalkerLJBowlingJAudisioRACowden syndromeCancer Treat Rev2010365778310.1016/j.ctrv.2010.04.00220580873Open DOISearch in Google Scholar
Dovnik A, Crnobrnja B, Zegura B, Takac I, Pakiz M. Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage. Radiol Oncol 2016; 51: 88-93. doi: 10.1515/ raon-2016-0035DovnikACrnobrnjaBZeguraBTakacIPakizMIncidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vsdilatation and curettage. Radiol Oncol201651889310.1515/raon-2016-0035533016428265237Open DOISearch in Google Scholar
Chen J, Clark LH, Kong WM, Yan Z, Han C, Zhao H, et al. Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma? PLoS One 2017; 12: e0174226. doi: 10.1371/journal.pone.0174226ChenJClarkLHKongWMYanZHanCZhaoHet alDoes hysteroscopy worsen prognosis in women with type II endometrial carcinoma?PLoS One201712e017422610.1371/journal.pone.0174226536386428334032Open DOISearch in Google Scholar
Biewenga P, de Blok S, Birnie E. Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings? Gynecol Oncol 2004; 93: 194-8. doi: 10.1515/raon-2016-0035BiewengaPdeBlok SBirnieE.Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings?Gynecol Oncol200493194810.1515/raon-2016-0035Open DOISearch in Google Scholar
Falcone F, Balbi G, Di Martino L, Grauso F, Salzillo ME, Messalli EM. Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithm. Med Sci Monit 2014; 20: 1298-313. doi: 10.12659/ MSM.890478FalconeFBalbiGDiMartino LGrausoFSalzilloMEMessalliEM.Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithmMed Sci Monit201420129831310.12659/MSM.890478413693225063051Open DOISearch in Google Scholar
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol 2012; 30: 695-700. doi: 10.1200/JCO.2011.38.8645WalkerJLPiedmonteMRSpirtosNMEisenkopSMSchlaerthJBMannelRSet alRecurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 StudyJ Clin Oncol20123069570010.1200/JCO.2011.38.8645329554822291074Open DOISearch in Google Scholar
Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2012; 207: 94-100. doi: 10.1016/j.ajog.2012.01.010ZulloFFalboAPalombaSSafety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trialsAm J Obstet Gynecol20122079410010.1016/j.ajog.2012.01.01022340944Open DOISearch in Google Scholar
Rabinovich A. Minimally invasive surgery for endometrial cancer. Curr Opin Obstet Gynecol 2015; 27: 302-7. doi: 10.1097/GCO.0000000000000187RabinovichAMinimally invasive surgery for endometrial cancerCurr Opin Obstet Gynecol201527302710.1097/GCO.000000000000018726134173Open DOISearch in Google Scholar
Bourgin C, Lambaudie E, Houvenaeghel G, Foucher F, Levêque J, Lavoué V. Impact of age on surgical staging and approaches (laparotomy, laparoscopy and robotic surgery) in endometrial cancer management. Eur J Surg Oncol 2017; 43: 703-9. doi: 10.1016/j.ejso.2016.10.022BourginCLambaudieEHouvenaeghelGFoucherFLevêqueJLavouéV.Impact of age on surgical staging and approaches (laparotomy, laparoscopy and robotic surgery) in endometrial cancer managementEur J Surg Oncol201743703910.1016/j.ejso.2016.10.022Open DOISearch in Google Scholar
Biler A, Solmaz U, Erkilinc S, Gokcu M, Bagci M, Temel O, et al. Analysis of endometrial carcinoma in young women at a high-volume cancer center. Int J Surg 2017; 44: 185-90. doi: 10.1016/j.ijsu.2017.06.083BilerASolmazUErkilincSGokcuMBagciMTemelOet alAnalysis of endometrial carcinoma in young women at a high-volume cancer centerInt J Surg2017441859010.1016/j.ijsu.2017.06.083Open DOISearch in Google Scholar
Sun C, Chen G, Yang Z, Jiang J, Yang X, Li N, et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis. Fertil Steril 2013; 100: 782-7. doi: 10.1016/j.fertnstert.2013.05.032SunCChenGYangZJiangJYangXLiNet alSafety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysisFertil Steril2013100782710.1016/j.fertnstert.2013.05.032Open DOISearch in Google Scholar
Gu H, Li J, Gu Y, Tu H, Zhou Y, Liu J. Survival impact of ovarian preservation on women with early-stage endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 2017; 27: 77-84. doi: 10.1097/ IGC.0000000000000857GuHLiJGuYTuHZhouYLiuJSurvival impact of ovarian preservation on women with early-stage endometrial cancer: a systematic review and meta-analysisInt J Gynecol Cancer201727778410.1097/IGC.0000000000000857Open DOISearch in Google Scholar
Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216: 459-76.e10. doi: 10.1016/j.ajog.2016.11.1033BodurthaSmith AJFaderANTannerEJ.Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysisAm J Obstet Gynecol201721645976e1010.1016/j.ajog.2016.11.1033Open DOISearch in Google Scholar
Bedyńska M, Szewczyk G, Klepacka T, Sachadel K, Maciejewski T, Szukiewicz D, et al. Sentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method. Arch Gynecol Obstet 2019; 299: 1373-84. doi: 10.1007/s00404-019-05063-6BedyńskaMSzewczykGKlepackaTSachadelKMaciejewskiTSzukiewiczDet alSentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the methodArch Gynecol Obstet201929913738410.1007/s00404-019-05063-6Open DOISearch in Google Scholar
Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial) : a multicentre, prospective, cohort study. Lancet Oncol 2017; 18: 384-92. doi: 10.1016/S1470-2045(17)30068-2RossiECKowalskiLDScaliciJCantrellLSchulerKHannaRKet alA comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial) : a multicentre, prospective, cohort studyLancet Oncol2017183849210.1016/S1470-2045(17)30068-2Open DOISearch in Google Scholar
Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 2012; 127: 5-10. doi: 10.1016/j.ygyno.2012.06.035DowdySCBorahBJBakkum-GamezJNWeaverALMcGreeMEHaasLRet alProspective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancerGynecol Oncol201212751010.1016/j.ygyno.2012.06.03522771890Open DOISearch in Google Scholar
Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 2014; 133: 216-20. doi: 10.1016/j.ygyno.2014.02.011VargasRRauh-HainJAClemmerJClarkRMGoodmanAGrowdonWBet alTumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysisGynecol Oncol20141332162010.1016/j.ygyno.2014.02.01124548726Open DOISearch in Google Scholar
Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006; 102: 92-7. doi: 10.1097/01.ogx.0000238643.54754.6aLutmanCVHavrileskyLJCragunJMSecordAACalingaertBBerchuckAet alPelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histologyGynecol Oncol200610292710.1097/01.ogx.0000238643.54754.6aOpen DOISearch in Google Scholar
Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, et al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 2008; 198: 457. e1-5; discussion 457.e5-6. doi: 10.1016/j.ajog.2008.01.010Abu-RustumNRIasonosAZhouQOkeESoslowRAAlektiarKMet alIs there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?Am J Obstet Gynecol2008198457e1-5; discussion 457.e5-610.1016/j.ajog.2008.01.010Open DOISearch in Google Scholar
Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-8. doi: 10.1016/j.ygyno.2008.01.023MarianiADowdySCClibyWAGostoutBSJonesMBWilsonTOet alProspective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical stagingGynecol Oncol200810911810.1016/j.ygyno.2008.01.023Open DOISearch in Google Scholar
AlHilli MM, Mariani A. The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol 2013; 18: 193-9. doi: 10.1007/s10147-013-0528-7AlHilliMMMarianiA.The role of para-aortic lymphadenectomy in endometrial cancerInt J Clin Oncol201318193910.1007/s10147-013-0528-7Open DOISearch in Google Scholar
Shih KK, Yun E, Gardner GJ, Barakat RR, Chi DS, Leitao MM. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol 2011; 122: 608-11. doi: 10.1016/j.ygyno.2011.05.020ShihKKYunEGardnerGJBarakatRRChiDSLeitaoMMSurgical cytoreduction in stage IV endometrioid endometrial carcinomaGynecol Oncol20111226081110.1016/j.ygyno.2011.05.020Open DOISearch in Google Scholar
van der Steen-Banasik E, Christiaens M, Shash E, Coens C, Casado A, Herrera FG, et al. Systemic review: radiation therapy alone in medical non-operable endometrial carcinoma. Eur J Cancer 2016; 65: 172-81. doi: 10.1016/j. ejca.2016.07.005vander Steen-Banasik EChristiaensMShashECoensCCasadoAHerreraFGetal.Systemic review: radiation therapy alone in medical non-operable endometrial carcinomaEur J Cancer2016651728110.1016/j.ejca.2016.07.005Open DOISearch in Google Scholar
Uccella S, Falcone F, Greggi S, Fanfani F, De Iaco P, Corrado G, et al. Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study. J Gynecol Oncol 2018; 29: e100. doi: 10.3802/jgo.2018.29.e100UccellaSFalconeFGreggiSFanfaniFDe IacoPCorradoGet alSurvival in clinical stage I endometrial cancer with single vsmultiple positive pelvic nodes: results of a multi-institutional Italian study. J Gynecol Oncol201829e10010.3802/jgo.2018.29.e100Open DOISearch in Google Scholar
Muallem MZ, Sehouli J, Richter R, Babayeva A, Gasimli K, Parashkevova A. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer. Int J Gynecol Cancer 2020; 30: 62-6. doi: 10.1136/ijgc-2019-000778MuallemMZSehouliJRichterRBabayevaAGasimliKParashkevovaAPre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancerInt J Gynecol Cancer20203062610.1136/ijgc-2019-000778Open DOISearch in Google Scholar
Lin YJ, Hu YW, Twu NF, Liu YM. The role of adjuvant radiotherapy in stage I endometrial cancer: a single-institution outcome. Taiwan J Obstet Gynecol 2019; 58: 604-9. doi: 10.1016/j.tjog.2019.07.005LinYJHuYWTwuNFLiuYMThe role of adjuvant radiotherapy in stage I endometrial cancer: a single-institution outcomeTaiwan J Obstet Gynecol201958604910.1016/j.tjog.2019.07.005Open DOISearch in Google Scholar
Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65. doi: 10.1016/0090-8258(91)90086-kMorrowCPBundyBNKurmanRJCreasmanWTHellerPHomesleyHDet alRelationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group studyGynecol Oncol199140556510.1016/0090-8258(91)90086-kOpen DOISearch in Google Scholar
Creasman W, Odicino F, Maisonneuve P, Quinn M, Beller U, Benedet J, et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet 2006; 95(Suppl 1): S105-43. doi: 10.1016/S0020-7292(06)60031-3CreasmanWOdicinoFMaisonneuvePQuinnMBellerUBenedetJet alCarcinoma of the corpus uteriInt J Gynaecol Obstet200695Suppl 1S1054310.1016/S0020-7292(06)60031-3Open DOISearch in Google Scholar
Rovirosa Á, Cortés KS, Ascaso C, Glickman A, Valdés S, Herreros A, et al. Are endometrial cancer radiotherapy results age related? Clin Transl Oncol 2018; 20: 1416-21. doi: 10.1007/s12094-018-1872-xRovirosaÁCortésKSAscasoCGlickmanAValdésSHerrerosAetal.Are endometrial cancer radiotherapy results age related?Clin Transl Oncol20182014162110.1007/s12094-018-1872-x29651671Open DOISearch in Google Scholar
Bestvina CM, Fleming GF. Chemotherapy for endometrial cancer in adjuvant and advanced disease settings. Oncologist 2016; 21: 1250-9. doi: 10.1634/ theoncologist.2016-0062BestvinaCMFlemingGFChemotherapy for endometrial cancer in adjuvant and advanced disease settingsOncologist2016211250910.1634/theoncologist.2016-0062506154127412393Open DOISearch in Google Scholar
Gressel GM, Parkash V, Pal L. Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer. Int J Gynaecol Obstet 2015; 131: 234-9. doi: 10.1016/j. ijgo.2015.06.031GresselGMParkashVPalLManagement options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancerInt J Gynaecol Obstet2015131234910.1016/j.ijgo.2015.06.03126384790Open DOISearch in Google Scholar
Kalogiannidis I, Agorastos T. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma. J Obstet Gynaecol 2011; 31: 13-7. doi: 10.3109/01443615.2010.532249KalogiannidisIAgorastosTConservative management of young patients with endometrial highly-differentiated adenocarcinomaJ Obstet Gynaecol20113113710.3109/01443615.2010.53224921280986Open DOISearch in Google Scholar
Carneiro MM, Lamaita RM, Ferreira MCF, Silva-Filho AL. Fertility-preservation in endometrial cancer: is it safe? Review of the literature. JBRA Assist Reprod 2016; 20: 232-9. doi: 10.5935/1518-0557.20160045CarneiroMMLamaitaRMFerreiraMCFSilva-FilhoALFertility-preservation in endometrial cancer: is it safe? Review of the literatureJBRA Assist Reprod201620232910.5935/1518-0557.20160045526562328050959Open DOISearch in Google Scholar
Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 2011; 205: 103-10. doi: 10.1016/j.ajog.2011.01.025EskanderRNRandallLMBermanMLTewariKSDisaiaPJBristowREFertility preserving options in patients with gynecologic malignanciesAm J Obstet Gynecol20112051031010.1016/j.ajog.2011.01.025511196721411052Open DOISearch in Google Scholar
Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Frigerio L, et al. Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol 2016; 37: 6-12. PMID: 27048101BoganiGDowdySCClibyWAGhezziFRossettiDFrigerioLet alManagement of endometrial cancer: issues and controversiesEur J Gynaecol Oncol201637612PMID: 27048101Search in Google Scholar
Zivanovic O, Carter J, Kauff ND, Barakat RR. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. Gynecol Oncol 2009; 115: 504-9. doi: 10.1016/j.ygyno.2009.08.011ZivanovicOCarterJKauffNDBarakatRRA review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancerGynecol Oncol2009115504910.1016/j.ygyno.2009.08.01119758691Open DOISearch in Google Scholar
Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, et al. Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device: Obstet Gynecol 2018; 131: 109-16. doi: 10.1097/AOG.0000000000002390PalNBroaddusRRUrbauerDLBalakrishnanNMilbourneASchmelerKMet alTreatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine deviceObstet Gynecol20181311091610.1097/AOG.0000000000002390573995529215513Open DOISearch in Google Scholar
Aslam RW, Pye KL, Rai TK, Hall B, Timmis LJ, Yeo ST, et al. Follow-up strategies for women with endometrial cancer after primary treatment. Cochrane Db Syst Rev 2016. doi: 10.1002/14651858.CD012386AslamRWPyeKLRaiTKHallBTimmisLJYeoSTet alFollow-up strategies for women with endometrial cancer after primary treatmentCochrane Db Syst Rev201610.1002/14651858.CD012386Open DOISearch in Google Scholar
